CARB-X, a non-profit partnership based at Boston University, is funding Avails Medical, a California-based diagnostics company, to develop an electronic antibiotic susceptibility testing (AST) device. Share this:TwitterFacebookLike this:Like Loading... You May Also Like Healthcare Technology 25-08-2021 ACOs generated $4.1B in gross savings in 2020, nearly double 2019 amount Healthcare Technology 13-05-2022 NHS Dorset Integrated Care System appoints a chief digital officer Healthcare Technology 09-11-2022 5 Trends Driving the Future Growth of Digital Health & MedTech Healthcare Technology 21-06-2021 Porvair invests in clean area for porous plastic components